Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16107513.
- Also identified by PMC identifier 1798053.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Glucocorticoids